Question 1

Does Renaissance Technologies own OCDX stock?

Accepted Answer

As of its Q1 2022 13F, Renaissance Technologies held 306,600 shares of OCDX (Ortho Clinical Diagnostics), worth $5.7M.

Question 2

How many shares of OCDX does Renaissance Technologies own?

Accepted Answer

As of its Q1 2022 13F, Renaissance Technologies held 306,600 shares of OCDX (Ortho Clinical Diagnostics).

Question 3

What is Renaissance Technologies' OCDX position worth?

Accepted Answer

As of its Q1 2022 13F, Renaissance Technologies' OCDX position was worth $5.7M.

Question 4

When did Renaissance Technologies first buy OCDX?

Accepted Answer

Renaissance Technologies first reported OCDX in its Q2 2021 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q1	Increased	306,600	+203.9%	$5.7M	0.0%	—	44
2021-Q4	Increased	100,900	+163.4%	$2.2M	0.0%	—	42
2021-Q3	Decreased	38,300	-82.9%	$708,000	0.0%	—	0
2021-Q2	New	224,300	-	$4.8M	0.0%	—	37

OCDX5 quarters

OCDX
5 quarters